Polycystic Ovary Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Potential associations of AMH and follistatin levels with PCOS-related parameters were compared between the subgroups as well as longitudinally before and in the first trimester of pregnancy.
|
29453653 |
2018 |
Polycystic Ovary Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
CRY decreased inhibin B and follistatin mRNA and protein expression but upregulated activin A mRNA and protein expression in the ovarian tissue of rats with PCOS (<i>P</i> < 0.05).
|
28559995 |
2017 |
Polycystic Ovary Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our results reveal that manifestation of PCOS-like phenotype following prenatal exposure to excess androgen is associated with irregularity in expression of the FST gene during the estrus cycle.
|
28277126 |
2017 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study demonstrates that methylation levels of CpG sites in the FST promoter and 5'-UTR are not associated with PCOS.
|
23265961 |
2013 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To screen the FST gene for mutations and to establish their association pattern with PCOS among a large cohort of South Indian women.
|
23023351 |
2013 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We conclude that FST is not a susceptibility locus for PCOS; however, the SNP rs3797297 from FST gene was associated with androgenic markers for PCOS and may be of importance in the hyperandrogenaemia of the disease.
|
17284512 |
2007 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
We conclude that FST is not a susceptibility locus for PCOS; however, the SNP rs3797297 from FST gene was associated with androgenic markers for PCOS and may be of importance in the hyperandrogenaemia of the disease.
|
17284512 |
2007 |
Polycystic Ovary Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genes for adrenal biosynthetic enzymes, insulin receptors, leptin and leptin receptors, follistatin, activin and inhibins are attractive candidates for polycystic ovarian disease.
|
12475548 |
2002 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the coding regions of the follistatin gene do not appear to be related to PCOS.
|
11334920 |
2001 |
Polycystic Ovary Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Follistatin and CYP11A, the genes with the strongest evidence for linkage with PCOS, are located on chromosomes 5 and 15.
|
11149629 |
2000 |
Polycystic Ovary Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
We conclude that contributions to the etiology of PCOS from the follistatin gene, if any, are likely to be small.
|
11134093 |
2000 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Therefore, it would appear that PCOS in the local Chinese population is not caused by mutations in the coding regions of the follistatin gene.
|
10871644 |
2000 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.
|
10411917 |
1999 |
Polycystic Ovary Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In both types of follicles, follistatin and alpha-, beta a-, and beta b-subunit cytoplasmic staining were observed in granulosa cells, as were their corresponding messages, with the exception of the undetectable follistatin mRNA signal in the PCOS follicles.
|
7962340 |
1994 |